Evaluation methods in disease management studies: 2004-07

Disease Management and Health Outcomes

Volumn 16, Issue 5, 2008, Pages 365-373

  Wilson, Thomas ^a,b   MacDowell, Martin ^a,c   Salber, Patricia ^a,d   Montrose, Gary ^a,e   Hamm, Carolyn ^a,f  

^a Population Health Impact Institute   (United States)

^b Trajectory Healthcare LLC   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

^d Universal American Corp   (United States)

^e Montrose Healthcare Strategies LLC   (United States)

^f WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Clinical trial design; Disease management programmes

Indexed keywords

HEALTH CARE PLANNING; HEALTH PROGRAM; HOSPITAL READMISSION; HUMAN; INTERVENTION STUDY; MORTALITY; NOTE; STANDARDIZATION;

EID: 57649217900     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/0115677-200816050-00014     Document Type: Note

References (57)

1. MacDowell M, Wilson TW. Framework for assessing causality in disease management programs [commissioned paper by Disease Management Association of America]. Washington, DC: DMAA, 2003
2. Outcomes Consolidation Steering Committee. Disease management program guide: including principles for assessing disease management programs. Washington, DC: DMAA, 2005: 33
3. Lindner A, Wilson T, Berg G, et al. Perspectives in disease management evaluation: health services research, epidemiology, econometrics, and actuarial. In: Hay J, Rindress D, editors. Measuring disease management. Yardley (PA): DMAA, 2007
4. Disease Management Association of America. Outcomes guidelines report. Vol. 3. Washington, DC: DMAA, 2008
5. American Healthways and Johns Hopkins University. Standard outcomes metrics and evaluation methodology of disease management programs. 2nd Annual Disease Management Outcomes Summit; 2002 Nov 7-10; Palm Springs (CA). Nashville (TN): American Healthways Inc., 2003
6. Glabman M. 'Take my word for it': the enduring dispute over measuring DM's economic value. Managed Care April 2006 [online]. Available from URL: http://managedcaremag.com/archives/0604/0604.dmvalue.html [Accessed 2008 Nov 27]
7. Disease Management Association of America. Outcomes guidelines report. Vol I. Washington, DC: DMAA, 2006
8. Disease Management Association of America. Outcomes guidelines report. Vol II. Washington, DC: DMAA, 2007
9. Mattke S, Bergamo G, Balakrishnan A, et al. Measuring and reporting the performance of disease management programs. Santa Monica (CA): RAND, 2006 Aug
10. Sexner S, Baker K, Gold D. Guidelines for analysis of economic returns from health management programs: the art of health promotion. Art Health Prom 2006 Jul/Aug: 1-17
11. Linden A. What will it take for DM to demonstrate a return on investment? New perspectives on an old theme. Am J Manag Care 2006; 12: 217-22
12. American Academy of Actuaries' Disease Management Work Group. Disease management: a public policy practice note. Washington, DC: American Academy of Actuaries, 2007
13. Weingarten SR, Henning JM, Badamgarav E, et al. Interventions used in disease management programmes for patients with chronic illness: which ones work? Meta-analysis of published reports. BMJ 2002; 325: 1-8
14. Ofman JJ, Badamgarav E, Henning JM, et al. Does disease management improve clinical and economic outcomes in patients with chronic diseases? A systematic review. Am J Med 2004; 117: 182-92
15. Holtz-Eakin D. An analysis of the literature on disease management programs. Congressional Budget Office, 2004 Oct [online]. Available from URL: http://www.cbo.gov/ftpdocs/59xx/doc5909/10-13-DiseaseMngmnt.pdf [Accessed 2008 Oct 28]
16. Krause D. Economic effectiveness of disease management: a metaanalysis. Dis Manage 2005; 8: 114-34
17. Goetzel RZ, Ozminkowski RJ, Villagra VG, et al. Return on investment in disease management: a review. Health Care Financ Rev 2005; 26: 1-19
18. Wilson TW, MacDowell M, Montrose G. The prerequisite importance of judging the potential usefulness of workplace health promotion studies: beyond "Published in a Peer-Reviewed Journal" and "Strength of Study Design". J Health Productivity 2006; 1: 23-8
19. Pelletier KR. A review and analysis of the clinical and cost-effectiveness studies of comprehensive health promotion and disease management programs at the worksite: update VI 2000-2004. J Occup Environ Med 2005 Oct; 47 (10): 1051-8
20. Mattke S, Seid M, Sai M. Evidence for the effect of disease management: is $1 billion a year a good investment? Am J Manag Care 2007; 13: 670-6
21. Martin DC, Berger ML, Anstatt DT, et al. A randomized controlled open trial of population-based disease and case management in a Medicare Plus Choice health maintenance organization. Prev Chronic Dis 2004; 1 (4): A05 [online]. Available from URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 1277945 [Accessed 2008 Nov 24]
22. Tinkelman D, Wilson S. Asthma disease management: regression to the mean or better? Am J Manag Care 2004 Dec; 10 (12): 948-54
23. Galbreath AD, Krasuski RA, Smith B, et al. Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. Circulation 2004; 110 (23): 3518-26
24. DeBusk RF, Miller NH, Parker KM, et al. Care management for low-risk patients with heart failure: a randomized, controlled trial. Ann Intern Med 2004; 141 (8): 606-13
25. Sackett K, Pope RK, Erdley WS. Demonstrating a positive return on investment for a prenatal program at a managed care organization: an economic analysis. J Perinat Neonatal Nurs 2004 Apr-Jun; 18 (2): 117-27
26. Villagra VG, Ahmed T. Effectiveness of a disease management program for patients with diabetes. Health Aff 2004; 23 (4): 255-66
27. Berg GD, Thomas E, Silverstein S, et al. Reducing medical service utilization by encouraging vaccines: randomized controlled trial. Am J Prev Med 2004 Nov; 27 (4): 284-8
28. Berg GD, Wadhwa S, Johnson AE. A matched-cohort study of health services utilization and financial outcomes for a heart failure disease-management program in elderly patients. J Am Geriatr Soc 2004 Oct; 52 (10): 1655-61
29. Scott JC, Conner DA, Venohr I, et al. Effectiveness of a group outpatient visit model for chronically ill older health maintenance organization members: a 2-year randomized trial of the cooperative health care clinic. J Am Geriatr Soc 2004 Sep; 52 (9): 1463-70
30. Rost K, Pyne JM, Dickinson LM, et al. Cost-effectiveness of enhancing primary care depression management on an ongoing basis. Ann Fam Med 2005 Jan-Feb; 3 (1): 7-14
31. Catov JM, Marsh GM, Youk AO, et al. Asthma home teaching: two evaluation approaches. Dis Manag 2005; 8 (3): 178-87
32. Hudson LR, Hamar GB, Orr P, et al. Remote physiological monitoring: clinical, financial, and behavioral outcomes in a heart failure population. Dis Manag 2005; 8 (6): 372-81
33. vanVonno CJ, Ozminkowski RJ, Smith MW, et al. What can a pilot congestive heart failure disease management program tell us about likely return on investment? A case study from a program offered to federal employees. Dis Manag 2005 Dec; 8 (6): 346-60
34. Delaronde S, Peruccio DL, Bauer BJ. Improving asthma treatment in a managed care population. Am J Manag Care 2005 Jun; 11 (6): 361-8
35. Dunagan WC, Littenberg B, Ewald GA, et al. Randomized trial of a nurse-administered, telephone-based disease management program for patients with heart failure. J Card Fail 2005 Jun; 11 (5): 358-65
36. Hawkins MR, Diehl-Svrjcek B, Dunbar LJ. Caring for children with special healthcare needs in the managed care environment. Lippincotts Case Manag 2006 Jul-Aug; 11 (4): 216-23
37. Schwerner H, Mellody T, Goldstein AB, et al. Evaluating the impact of a disease management program for chronic complex conditions at two large northeast health plans using a control group methodology. Dis Manag 2006 Feb; 9 (1): 34-44
38. Wise CG, Bahl V, Mitchell R, et al. Population-based medical and disease management: an evaluation of cost and quality. Dis Manag 2006 Feb; 9 (1): 45-55
39. Daly BJ, Douglas SL, Kelley CG, et al. Trial of a disease management program to reduce hospital readmissions of the chronically critically ill. Chest 2005 Aug; 128 (2): 507-17
40. Sidorov J. Reduced health care costs associated with disease management for chronic heart failure: a study using three methods to examine the financial impact of a heart failure disease management program among medicare advantage enrollees. J Card Fail 2006 Oct; 12 (8): 594-600
41. Grypma L, Haverkamp R, Little S, et al. Taking an evidence-based model of depression care from research to practice: making lemonade out of depression. Gen Hosp Psychiatry 2006 Mar-Apr; 28 (2): 101-7
42. Shannon GR, Wilber KH, Allen D. Reductions in costly healthcare service utilization: findings from the Care Advocate Program. J Am Geriatr Soc 2006 Jul; 54 (7): 1102-7
43. Firestone B, Bartlett J, Selby J. Can disease management reduce health care costs by improving quality? Health Aff 2004; 23 (6): 63-75
44. Sweeney L, Halpert A, Waranoff J. Patient-centered management of complex patients can reduce costs without shortening life. Am J Manag Care 2007; 13: 84-92
45. Nguyen HQ, Ackerman R. Impact of a managed-Medicare physical activity benefit on health care utilization and costs in older adults with diabetes. Diabetes Care Jan 2007; 30 (1): 43-8
46. Centre for Evidence-Based Medicine. Levels of evidence [online]. Available from URL: http://www.cebm.net/index.aspx?o=1025 [Accessed 2008 Nov 27]
47. Agency for Healthcare Research and Quality. US Preventive Services Task Force [online]. Available from URL: http://www.ahrq.gov/clinic/uspstf/ uspstopics.htm [Accessed 2008 Nov 27]
48. Consolidated Standards of Reporting Trials (CONSORT) [online]. Available from URL: http://www.consort-statement.org/?o=1011 [Accessed 2008 Nov 27]
49. The Cochrane Collaboration [online]. Available from URL: http://www.cochrane.org/ [Accessed 2008 Nov 27]
50. Des Jarlais DC, Lyles C, Crepaz N, the TREND Group. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health 2004; 94 (3): 361-6
51. Chen A, Brown R, Archibald N, et al. Best practices in coordinated care. Mathematica 2000 [online]. Available from URL: http://www.mathematica-mpr.com/ publications/PDFs/bestpractices.pdf [Accessed 2008 Nov 27]
52. Wilson TW, Gruen J, Thar W, et al. Assessing return on investment of defined-population disease management interventions. Jt Comm J Qual Saf 2004; 30 (11): 614-21
53. Fitzner K, Siderov J, Fetterolf D, et al. Principles for assessing disease management outcomes. Dis Manage 2004; 7: 191-201
54. Faxon DP, Schwamm LH, Pasternak RC, et al. American Heart Association's Expert Panel on Disease Management. Improving quality of care through disease management: principles and recommendations from the American Heart Association's Expert Panel on Disease Management. Circulation 2004 Jun 1; 109 (21): 2651-4
55. Krumholz HM, Brindis RG, Brush JE, et al. Standards for statistical models used for public reporting of health outcomes. Circulation 2006; 113: 456-62
56. Linden A, Roberts N. A user's guide to the disease management literature: recommendations for reporting and assessing program outcomes. Am J Manage Care 2005; 11 (2): 81-90
57. Duncan I, Owen R, Dove H. Testing actuarial methods for evaluating disease management savings outcomes. Society of Actuaries, 2006 [online]. Available from URL: http://www.soa.org/research/files/pdf/ Paper_8_TestingActuarial%20Methods.pdf [Accessed 2008 Nov 27]